1-17 of 17
Enrique Bengoechea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarkers for Predicting Long-Term Disease Control in Transplant-Ineligible Multiple Myeloma Patients: The Presence of an MGUS- like Signature Is the Most Relevant Predictor

Paula Rodriguez Otero, MD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez Lopez, MD PhD, Miguel-Teodoro Hernández, Enrique M. Ocio, MD, Laura Rosiñol, Rafael Martínez, MD, Ana Isabel Teruel, MDcal Doctor, Norma C. Gutierrez, MD PhD, Joan Bargay, MD PhD, Enrique Bengoechea, Yolanda Gonzalez-Montes, Jaime Perez De Oteyza, MD PhD, Mercedes Gironella, MD, Cristina Encinas, Jesús Martín, Carmen Cabrera, Luis Palomera, MD PhD, Felipe De Arriba, PhD, Maria Teresa Cedena Romero, MD PhD, Noemi Puig, MD PhD, Albert Oriol, MD, Bruno Paiva, MD PhD, Joan Bladé, MD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4503.
https://doi.org/10.1182/blood-2018-99-117431
Published: 2018
Journal Articles

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Laura Rosinol Dachs, Albert Oriol, MD, Ana Isabel Teruel, MDcal Doctor, Ana López de la Guía, M Jesús Blanchard, Isidro Jarque, Miquel Granell, MD, Antonia Sampol, Luis Palomera, MD PhD, Yolanda Gonzalez-Montes, Enrique Bengoechea, Rafael Martínez-Martínez, Miguel T Hernández, MD PhD, Felipe De Arriba, PhD, Maria Luisa Martin-Ramos, Norma C. Gutierrez, MD PhD, Maria Teresa Cibeira, MD PhD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez-Lopez, MD PhD, Adrián Alegre, MD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD, Joan Blade, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 126.
https://doi.org/10.1182/blood-2018-99-111924
Published: 2018
Journal Articles

The Poor Prognosis of High Cytogenetics Abnormalities in Elderly Patients Might be Overcome with an Optimized Total Therapy Approach Including Proteasome Inhibitors, Imid's Compounds and Alkylators

Maria-Victoria Mateos, MD PhD, Norma C Gutierrez, MD PhD, María-Luisa Martín, Joaquín Martínez-López, MD PhD, Miguel-T Hernandez, Enrique M. Ocio, MD PhD, Laura Rosiñol, Rafael Martinez, MD, Ana Isabel Teruel, MD, Albert Oriol, Joan Bargay, MD, Enrique Bengoechea, Yolanda Gonzalez, Jaime Perez de Oteyza, Mercedes Gironella, Cristina Encinas, Jesus Martin, Carmen Cabrera, Bruno Paiva, PhD, Noemi Puig, MD PhD, Joan Bladé, Juan José Lahuerta, MD PhD, Jesus San Miguel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5688.
https://doi.org/10.1182/blood.V128.22.5688.5688
Published: 2016
Journal Articles

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM

Clinical Trials & Observations
María-Victoria Mateos, Joaquín Martínez-López, Miguel-Teodoro Hernández, Enrique-M. Ocio, Laura Rosiñol, Rafael Martínez, Ana-Isabel Teruel, Norma C. Gutiérrez, María-Luisa Martín Ramos, Albert Oriol, Joan Bargay, Enrique Bengoechea, Yolanda González, Jaime Pérez de Oteyza, Mercedes Gironella, Cristina Encinas, Jesús Martín, Carmen Cabrera, Bruno Paiva, María-Teresa Cedena, Noemí Puig, Joan Bladé, Juan-José Lahuerta, Jesús San-Miguel
Journal: Blood
Blood (2016) 127 (4): 420–425.
https://doi.org/10.1182/blood-2015-08-666537
Published: 2016
Journal Articles

Bortezomib Plus Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) in Newly Diagnosed Elderly Myeloma Patients Overcome the Poor Prognosis of High-Risk Cytogenetic Abnormalities (CA) Detected By Fluorescence in Situ Hibridization (FISH)

Maria-Victoria Mateos, Norma C Gutierrez, María-Luisa Martín, Joaquín Martínez-López, MD PhD, Miguel T Hernandez, Rafael Martinez, MDPhD, Laura Rosiñol, MDPhD, Enrique M. Ocio, MD PhD, Ana Isabel Teruel, MD, Albert Oriol, MDPhD, Juan Jose Bargay, Enrique Bengoechea, Yolanda Gonzalez, MD, Jaime Perez De Oteyza, Mercedes Gironella, Cristina Encinas, Jesus Martin, Carmen Cabrera, Bruno Paiva, PhD, Noemi Puig, MD PhD, Joan Blade, MDPhD, Juan José Lahuerta, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4243.
https://doi.org/10.1182/blood.V126.23.4243.4243
Published: 2015
Journal Articles

Bortezomib, Melphalan, Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) Is the Optimal Combination for Patients with Newly Diagnosed Multiple Myeloma (MM) Patients Between 65 and 80 Years

Maria-Victoria Mateos, MD PhD, Joaquín Martínez-López, Miguel T Hernandez, Enrique M Ocio, Laura Rosiñol, MDPhD, Rafael Martinez, MD, Ana Isabel Teruel, MD, Norma C Gutierrez, María-Luisa Martín, Albert Oriol, MD, Joan Bargay, MD, Enrique Bengoechea, Yolanda Gonzalez, MD, Jaime Perez de Oteyza, Mercedes Gironella, Cristina Encinas, Carmen Cabrera, Bruno Paiva, PhD, Maria Teresa Cedena, Noemi Puig, MD PhD, Joan Blade, MDPhD, Juan José Lahuerta, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1848.
https://doi.org/10.1182/blood.V126.23.1848.1848
Published: 2015
Journal Articles

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality

Clinical Trials & Observations Brief Report
Joaquín Martínez-López, Bruno Paiva, Lucía López-Anglada, María-Victoria Mateos, Teresa Cedena, María-Belén Vidríales, María Auxiliadora Sáez-Gómez, Teresa Contreras, Albert Oriol, Inmaculada Rapado, Ana-Isabel Teruel, Lourdes Cordón, María Jesús Blanchard, Enrique Bengoechea, Luis Palomera, Felipe de Arriba, Cecilia Cueto-Felgueroso, Alberto Orfao, Joan Bladé, Jesús F. San Miguel, Juan José Lahuerta
Journal: Blood
Blood (2015) 126 (7): 858–862.
https://doi.org/10.1182/blood-2015-04-638742
Published: 2015
Journal Articles

GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?

Clinical Trials & Observations
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Ana-Isabel Teruel, Ana López de la Guía, Javier López, Enrique Bengoechea, Montserrat Pérez, Rafael Martínez, Luis Palomera, Felipe de Arriba, Yolanda González, José Mariano Hernández, Miquel Granell, José-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, María-Luisa Martín-Mateos, Bruno Paiva, María-Angeles Montalbán, Joan Bladé, Juan-Jose Lahuerta, Jesús F. San-Miguel
Journal: Blood
Blood (2014) 124 (12): 1887–1893.
https://doi.org/10.1182/blood-2014-05-573733
Published: 2014
Journal Articles

CD56 + Clonal Plasma Cells In Multiple Myeloma Are Associated With Unique Disease Characteristics and Have a Counterpart Of CD56 + Normal Plasma Cells With Increased Maturity

Martin Schmidt-Hieber, Bruno Paiva, Martin Perez-Andres, PhD, Maria Laura Gutierrez, Karen Dybkaer, PhD, Ana Rasillo, Maria Dolores Tabernero, Antonio Lopez, Fedor Kryukov, Paloma Carrasco, Maria Luz Sanchez, Laura Rosiñol, MD, Joaquin Martinez Lopez, Consultant, Albert Oriol, MD, Felipe de Arriba, Luis Palomera, MD, Enrique Bengoechea, Juan Jose Lahuerta, MD, Joan Blade, MD, Alex Schmitz, Hans E Johnsen, Jesús F San Miguel, MD, Alberto Orfao
Journal: Blood
Blood (2013) 122 (21): 751.
https://doi.org/10.1182/blood.V122.21.751.751
Published: 2013
Journal Articles

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

Clinical Trials & Observations
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Ana López de la Guía, Javier López, Enrique Bengoechea, Montserrat Pérez, Marta Polo, Luis Palomera, Felipe de Arriba, Yolanda González, Jose-Mariano Hernández, Miquel Granell, José-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, José-María Ribera, María-Luisa Martín-Mateos, Ramón García-Sanz, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel
Journal: Blood
Blood (2012) 120 (13): 2581–2588.
https://doi.org/10.1182/blood-2012-05-427815
Published: 2012
Includes: Supplemental data
Journal Articles

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Bruno Paiva, Norma C. Gutierrez, Xi Chen, María-Belén Vidriales, María-Angeles Montalbán, Laura Rosiñol, MD, Albert Oriol, Joaquín Martínez-López, MD, Maria Victoria Mateos, Lucía López-Corral, Elena Díaz-Rodríguez, Jose J. Perez, Elena Fernandez-Redondo, Felipe de Arriba, Luis Palomera, Enrique Bengoechea, María José Terol, MD, PhD, Raquel de Paz, Alejandro Martín, Jose Hernández, Alberto Orfao, MD, PhD, Juan José Lahuerta, Joan Blade, Atanasio Pandiella, Jesus F. San Miguel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3936.
https://doi.org/10.1182/blood.V118.21.3936.3936
Published: 2011
Journal Articles

Influence of Genetic Polymorphisms in CYP1A2 , CYP2C19, CYP3A4 , GSTP1 , MDR1 and PSMB5 Genes in Toxicity and Response to Induction Therapy in Multiple Myeloma Patients Included in the Trial of the Spanish PETHEMA/GEM 05 for Newly Diagnosed MM Elderly Patients (Age 65 or More)

Cristina Castilla-Llorente, Felipe de Arriba, Virginia Pérez-Andreu, Maria Victoria Mateos, Rocio González-Conejero, José Rivera Pozo, Albert Oriol, Joaquin Martínez-López, Ana Isabel Teruel, Raquel de Paz, José García-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Luis Palomera, Yolanda Gonzalez, Jose Mariano Hernández, Anna Sureda, Jose Luis Bello, Joan Bargay, Francisco Javier Peñalver, Maria Luisa Martin Mateos, María Teresa Cibeira, Juan José Lahuerta, Joan Blade, Jesús F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 1412.
https://doi.org/10.1182/blood.V118.21.1412.1412
Published: 2011
Journal Articles

Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial

María-Victoria Mateos, MD, PhD, Albert Oriol, Ana-Isabel Teruel, Enrique Bengoechea, Montse Pérez, Javier López, Joaquín Díaz-Mediavilla, Jose Mariano Hernández, Felipe de Arriba, Yolanda Gonzalez, Joan Bladé, MD, Juan José Lahuerta, Jesðs F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 477.
https://doi.org/10.1182/blood.V118.21.477.477
Published: 2011
Journal Articles

Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

Clinical Trials & Observations
María-Victoria Mateos, Norma C. Gutiérrez, María-Luisa Martín-Ramos, Bruno Paiva, María-Angeles Montalbán, Albert Oriol, Joaquín Martínez-López, Ana-Isabel Teruel, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Felipe de Arriba, Luis Palomera, José-Mariano Hernández, Anna Sureda, Joan Bargay, Francisco-Javier Peñalver, Josep-Maria Ribera, María-Luisa Martín-Mateos, Manuela Fernández, Ramón García-Sanz, María-Belén Vidriales, Joan Bladé, Juan-José Lahuerta, Jesús F. San Miguel
Journal: Blood
Blood (2011) 118 (17): 4547–4553.
https://doi.org/10.1182/blood-2011-04-345801
Published: 2011
Journal Articles

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

María-Victoria Mateos, Norma C. Gutierrez, Bruno Paiva, Albert Oriol, Joaquín Martínez-López, Ana Isabel Teruel, Raquel de Paz, Jose Garcia-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Luis Palomera, Yolanda Gonzalez, Jose Mariano Hernández, Ana Sureda, Jose Luis Bello, Joan Bargay, Francisco-Javier Penalver, Josep-Maria Ribera, MD, PhD, María-Luisa Martín-Mateos, Ramón García-Sanz, María Teresa Cibeira, MD, PhD, María-Luisa Martín-Ramos, María-Belén Vidriales, María-Angeles Montalbán, Juan-Jose Lahuerta, Joan Blade, Jesús F. San Miguel, Sr, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 309.
https://doi.org/10.1182/blood.V116.21.309.309
Published: 2010
Journal Articles

A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years.

Maria-Victoria Mateos, MD, PhD, Albert Oriol, MD, Joaquin Martinez, MD, M Teresa Cibeira, Norma C. Gutiérrez, Maria Jose Terol, MD, Raquel de Paz, MD, PhD, Jose García-Laraña, Enrique Bengoechea, Alejandro Martín García-Sancho, Rafael Martínez, Luis Palomera, Felipe de Arriba, Yolanda Gonzalez, José Hernández, Anna Sureda, MD, PhD, Jose-Luis Bello, Juan José Lahuerta, MD, PhD, Joan Blade, M.D., Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3.
https://doi.org/10.1182/blood.V114.22.3.3
Published: 2009
Journal Articles

Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade- Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?

Maria-Victoria Mateos, Albert Oriol, Joaquín Martínez, Ma Teresa Cibeira, Raquel de Paz, Ma José Terol, José García-Laraña, Enrique Bengoechea, Rafael Martínez, Alejandro Martin, Felipe de Arriba, Luis Palomera, José Hernández, Jose-Luis Bello, María-Luisa Martín, Yolanda González, Joan Blade, MD, Juan José Lahuerta, J.F San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 651.
https://doi.org/10.1182/blood.V112.11.651.651
Published: 2008